Related references
Note: Only part of the references are listed.CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification
Shurui Zhou et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
DNA methylation in cell plasticity and malignant transformation in liver diseases
Minwook Kim et al.
PHARMACOLOGY & THERAPEUTICS (2023)
Proteogenomic characterization of cholangiocarcinoma
Mengjie Deng et al.
HEPATOLOGY (2023)
MicroRNA-27a-3p targets FoxO signalling to induce tumour- like phenotypes in bile duct cells
Lea Duwe et al.
JOURNAL OF HEPATOLOGY (2023)
Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma
Naoshi Nishida et al.
CANCERS (2023)
Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
Fumimasa Tomooka et al.
CELLS (2023)
Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis
Guangxin Wang et al.
ANTI-CANCER DRUGS (2023)
Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer
Yanyan Wang et al.
NON-CODING RNA (2023)
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy
Juan Jose Soto-Castillo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2023)
Cholangiocarcinoma: Molecular Abnormalities and Cells of Origin
Ugo Testa et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2023)
A Comprehensive Study on Signal Transduction and Therapeutic Role of miR-877 in Human Cancers
Milad Rafat et al.
ADVANCED BIOMEDICAL RESEARCH (2023)
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples
Eleonora Loi et al.
BRITISH JOURNAL OF CANCER (2022)
Integrative epigenomic profiling reveal AP-1 is a key regulator in
Ke He et al.
GENOMICS (2022)
SAHA induce hippo pathway in CCA cells without increasing cell proliferation
Merve Ozel et al.
MOLECULAR BIOLOGY REPORTS (2022)
Epigenetic Silencing of 15-Hydroxyprostaglandin Dehydrogenase by Histone Methyltransferase EHMT2/G9a in Cholangiocarcinoma
Jinqiang Zhang et al.
MOLECULAR CANCER RESEARCH (2022)
Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma
Hironori Yamashita et al.
VIRCHOWS ARCHIV (2022)
Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma
Meng-Ju Wu et al.
CANCER DISCOVERY (2022)
Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
Yongpan Li et al.
STEM CELLS INTERNATIONAL (2022)
Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription
Qinjunjie Chen et al.
JOURNAL OF HEPATOLOGY (2022)
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
Monica Niger et al.
MOLECULAR ONCOLOGY (2022)
Arid1a mutation suppresses TGF-? signaling and induces cholangiocarcinoma
Bing Guo et al.
CELL REPORTS (2022)
Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma
Christian Prinz et al.
GENES (2022)
Ten-Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild-Type Isocitrate Dehydrogenase 1
Xuewei Bai et al.
HEPATOLOGY (2021)
Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis
Sayed Obaidullah Aseem et al.
GASTROENTEROLOGY (2021)
Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesis
Guang Yang et al.
EMBO REPORTS (2021)
Emerging role of SWI/SNF complex deficiency as a target of immune checkpoint blockade in human cancers
Min Zhou et al.
ONCOGENESIS (2021)
Protein-loss of SWI/SNF-complex core subunits influences prognosis dependent on histological subtypes of intra- and extrahepatic cholangiocarcinoma
Britta Janina Wagner et al.
ONCOLOGY LETTERS (2021)
Cholangiocarcinoma: new perspectives for new horizons
Margherita Rimini et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Transcriptome and DNA methylation analysis reveals molecular mechanisms underlying intrahepatic cholangiocarcinoma progression
Yuming Peng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
OPCML Exerts Antitumor Effects in Cholangiocarcinoma via AXL/STAT3 Inactivation and Rho GTPase Down-regulation
Ricuphan Khamko et al.
CANCER GENOMICS & PROTEOMICS (2021)
The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma
Sha Qin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression
Napat Armartmuntree et al.
JOURNAL OF CANCER (2021)
Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)
Chunlong Zhao et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis
Gabor Lendvai et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Cholangiocarcinoma
Aikaterini Mastoraki et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression
Yang Yu et al.
CANCER SCIENCE (2020)
Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
Kishor Pant et al.
CELLS (2020)
ARID1A alterations and their clinical significance in cholangiocarcinoma
Achira Namjan et al.
PEERJ (2020)
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
Ping Zhang et al.
CLINICAL EPIGENETICS (2020)
Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges
Yang Yang et al.
CANCER COMMUNICATIONS (2020)
Molecular Pathogenesis of Cholangiocarcinoma
Peter L. Labib et al.
BMC CANCER (2019)
Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis
Mingming Zhang et al.
CELL COMMUNICATION AND SIGNALING (2019)
Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases
Wiphawan Wasenang et al.
CLINICAL EPIGENETICS (2019)
LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells
Xinglei Qin et al.
CELL CYCLE (2019)
Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway
Lei Kong et al.
CELL CYCLE (2019)
The SIRT2/cMYC Pathway Inhibit Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
Lei Xu et al.
NEOPLASIA (2019)
Long noncoding RNA DANCR regulates proliferation and migration by epigenetically silencing FBP1 in tumorigenesis of cholangiocarcinoma
Ni Wang et al.
CELL DEATH & DISEASE (2019)
Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors
Laura L. Meijer et al.
CANCERS (2019)
Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma
Cheng Zhang et al.
CANCER CELL INTERNATIONAL (2019)
Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma
Benjamin Goeppert et al.
HEPATOLOGY (2019)
DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype
Younghoon Kim et al.
VIRCHOWS ARCHIV (2019)
Epigenome Remodeling in Cholangiocarcinoma
Colm J. O'Rourke et al.
TRENDS IN CANCER (2019)
SAHA modulates cell proliferation, colony forming and epithelial-mesenchymal transition in CCA cells
Gulden Baskol et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI (2019)
Epigenetic drivers of tumourigenesis and cancer metastasis
Aniruddha Chatterjee et al.
SEMINARS IN CANCER BIOLOGY (2018)
Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review
Gyem Tshering et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Targeting cholangiocarcinoma
Joachim C. Mertens et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Current Insights into Oral Cancer Epigenetics
Alexandra Iulia Irimie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression
Diana Gulei et al.
CELL DEATH & DISEASE (2018)
Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma
Yang Yu et al.
CELL DEATH & DISEASE (2018)
Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma
Georgi Atanasov et al.
Oncotarget (2018)
miR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in Cholangiocarcinoma
Peng-Cheng Kang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma
Xiang Wang et al.
CANCER BIOMARKERS (2018)
Long Non-coding RNA PVT1 Promotes Cell Proliferation and Migration by Silencing ANGPTL4 Expression in Cholangiocarcinoma
Yang Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
PBRM1 loss is a late event during the development of cholangiocarcinoma
Claudio Luchini et al.
HISTOPATHOLOGY (2017)
Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma
Toshiaki Nakaoka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Acetylation on histone H3 lysine 9 mediates a switch from transcription initiation to elongation
Leah A. Gates et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells
Wenlong Cheng et al.
CELL DEATH & DISEASE (2017)
Identification of microRNAs as biomarkers for cholangiocarcinoma detection: A diagnostic meta-analysis
J. Zhou et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Down-regulation of HDAC3 inhibits growth of cholangiocarcinoma by inducing apoptosis
Mingming Zhang et al.
ONCOTARGET (2017)
The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer
Hwajeong Lee et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)
CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway
Dawoon E. Jung et al.
SCIENTIFIC REPORTS (2017)
Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation Impact on Regulation of Notch Pathway
Hyunjoo Kwon et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma
Seorin Jeong et al.
BMC CANCER (2017)
The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer
Feng Jiang et al.
ONCOLOGY REPORTS (2016)
Advances in biomarkers of biliary tract cancers
Jun Hu et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Biliary Cancer: Utility of Next-Generation Sequencing for Clinical Management
Milind Javle et al.
CANCER (2016)
Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice
Apurva Jain et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma
Benjamin Goeppert et al.
EPIGENETICS (2016)
New genomic landscapes and therapeutic targets for biliary tract cancers
Michele Simbolo et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2016)
Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells
Wenjie Zhou et al.
ONCOLOGY REPORTS (2016)
Coding-noncoding gene expression in intrahepatic cholangiocarcinoma
Jianguo Wang et al.
TRANSLATIONAL RESEARCH (2016)
The current management of cholangiocarcinoma: A comparison of current guidelines
Yulong Cai et al.
BIOSCIENCE TRENDS (2016)
The pathways of genetic transformation in cholangiocarcinogenesis
Francesco M. Serafini et al.
CANCER GENETICS (2016)
TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors
Jun-chuang He et al.
ONCOTARGET (2016)
Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract
V. Branchi et al.
CLINICAL EPIGENETICS (2016)
Epigenetic regulation in the carcinogenesis of cholangiocarcinoma
Nai-Jung Chiang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma
Torsten Voigtlaender et al.
PLOS ONE (2015)
DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma
Rattaya Amornpisutt et al.
TUMOR BIOLOGY (2015)
Role of epigenetic modifications in luminal breast cancer
Hany A. Abdel-Hafiz et al.
EPIGENOMICS (2015)
MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN
Li-Juan Wang et al.
ONCOTARGET (2015)
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
Hege Marie Vedeld et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
Chaitanya R. Churi et al.
PLOS ONE (2014)
P16 Hypermethylation Predicts Surgical Outcome Following Curative Resection of Mid/Distal Bile Duct Cancer
Joon Seong Park et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Histone Deacetylases and their Inhibitors as Potential Therapeutic Drugs for cholangiocarcinoma - Cell Line findings
Ruethairat Sriraksa et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Aberrant DNA Methylation at Genes Associated with a Stem Cell-like Phenotype in Cholangiocarcinoma Tumors
Ruethairat Sriraksa et al.
CANCER PREVENTION RESEARCH (2013)
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P. Wang et al.
ONCOGENE (2013)
The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
A. Hunter Shain et al.
PLOS ONE (2013)
The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models
Pietro Di Fazio et al.
ONCOLOGY LETTERS (2013)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
The HAT/HDAC interplay: Multilevel control of STAT signaling
Laura Icardi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
Kim Andresen et al.
EPIGENETICS (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Role of histone deacetylase expression in intrahepatic cholangiocarcinoma
Yuji Morine et al.
SURGERY (2012)
Correlation between promoter methylation of p14ARF, TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma
Liu Xiaofang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer
Kengo Shigehara et al.
PLOS ONE (2011)
Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines
Shuichi Iwahashi et al.
JOURNAL OF MEDICAL INVESTIGATION (2011)
A decade of exploring the cancer epigenome - biological and translational implications
Stephen B. Baylin et al.
NATURE REVIEWS CANCER (2011)
Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma
Junpei Yamaguchi et al.
CANCER SCIENCE (2010)
Transcriptional induction of minichromosome maintenance protein 7 (Mcm7) in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products
Dong-Wook Kim et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2010)
New insights on cholangiocarcinoma
Manuela Gatto et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Nucleosome positioning and gene regulation: advances through genomics
Cizhong Jiang et al.
NATURE REVIEWS GENETICS (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma
Feng Ye et al.
CANCER INVESTIGATION (2008)
Mechanisms of biliary carcinogenesis and growth
Candace Wise et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Tumor progression through epigenetic gene silencing of O6-methylguanine-DNA methyltransferase in human biliary tract cancers
Y Koga et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma
T Limpaiboon et al.
CANCER LETTERS (2005)
Share Paper
